Hemorrhagic Fever, Ebola
Information
- Disease name
- Hemorrhagic Fever, Ebola
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05284097 | Active, not recruiting | Phase 2 | Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study | September 19, 2022 | May 31, 2024 |
| NCT05067166 | Available | Open-Label Expanded Access for Ebola-Infected Patients to Receive Human mAb Ansuvimab as Therapeutic or for HR PEP | |||
| NCT02342171 | Completed | Phase 2/Phase 3 | Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea | February 2015 | July 2015 |
| NCT02354404 | Completed | Phase 1 | Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda | January 27, 2015 | April 19, 2017 |
| NCT02378753 | Completed | Phase 2/Phase 3 | STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola) | April 2015 | December 5, 2016 |
| NCT02564523 | Completed | Phase 2 | Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults | November 6, 2015 | February 12, 2019 |
| NCT00072605 | Completed | Phase 1 | Experimental Ebola Vaccine Trial | October 30, 2003 | August 22, 2007 |
| NCT02598388 | Completed | Phase 2 | Safety, Tolerability and Immunogenicity Study of 2-dose Heterologous Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo | December 10, 2015 | December 12, 2018 |
| NCT02911428 | Completed | Open Study of the Duration of Immunity After Vaccination With GamEvac | October 2016 | December 25, 2017 | |
| NCT02564575 | Completed | Phase 1 | Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults | August 2015 | November 2016 |
| NCT02283099 | Completed | Phase 1 | Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP) | November 2014 | November 2015 |
| NCT02661464 | Terminated | Phase 3 | Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo | May 31, 2016 | December 13, 2021 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D019142